The disruption of STING signaling relieves the lupus development in FCGR2B-deficient mice, and the transplantation of STING-activated bone marrow-derived dendritic cells into the mice with both FCGR2B and STING defects restores the lupus phenotype (115). The gene discussed is FCGR2B; the disease is systemic lupus erythematosus.